Cargando…
Isoliquiritigenin Attenuates Atherogenesis in Apolipoprotein E-Deficient Mice
Isoliquiritigenin (ISL) exhibits antioxidation and anti-inflammation activity. We sought to investigate the effects and mechanism of ISL on the development of atherosclerotic lesions in apolipoprotein E-deficient (apoE(−/−)) mice. Firstly, we determined that ISL reduced the mRNA levels of inflammato...
Autores principales: | Du, Fen, Gesang, Quzhen, Cao, Jia, Qian, Mei, Ma, Li, Wu, Dongfang, Yu, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133927/ https://www.ncbi.nlm.nih.gov/pubmed/27869741 http://dx.doi.org/10.3390/ijms17111932 |
Ejemplares similares
-
CFTR protects against vascular inflammation and atherogenesis in apolipoprotein E-deficient mice
por: Li, Zhengzhang, et al.
Publicado: (2017) -
BubR1 Insufficiency Results in Decreased Macrophage Proliferation and Attenuated Atherogenesis in Apolipoprotein E‐Deficient Mice
por: Tanaka, Shinichi, et al.
Publicado: (2016) -
BubR1 Insufficiency Results in Decreased Macrophage Proliferation and Attenuated Atherogenesis in Apolipoprotein E‐Deficient Mice
Publicado: (2017) -
Inhibition of S1P Receptor 2 Attenuates Endothelial Dysfunction and Inhibits Atherogenesis in Apolipoprotein E-Deficient Mice
por: Ganbaatar, Byambasuren, et al.
Publicado: (2021) -
Arsenic exposure accelerates atherogenesis in apolipoprotein E(-/-) mice.
por: Simeonova, Petia P, et al.
Publicado: (2003)